SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950123-00-007095
Filing Date
2000-08-02
Accepted
2000-08-02 00:00:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #2 TO SCHEDULE 13D: CLINICHEM/BIOCHEM sc13da.txt SC 13D/A 9502
2 SHARE PURCHASE AGREEMENT ex99-1.txt EX-99.1 27051
  Complete submission text file 0000950123-00-007095.txt   38794
Mailing Address 275 ARMAND FRAPPIER BLVD LAVAL QUEBEC E6
Business Address 275 ARMAND-FRAPPIER BLVD LAVAL QUEBEC E6 5146811744
BIOCHEM PHARMA INC (Filed by) CIK: 0000867202 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E6 | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 275 ARMAND FRAPPIER BOULEVARD LAVAL PROVICE QUEBEC A8 00000 5146811744
CLINICHEM DEVELOPMENT INC (Subject) CIK: 0001054396 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-54385 | Film No.: 684801
SIC: 2834 Pharmaceutical Preparations